Addex Therapeutics Ltd ADR
(ADXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,112 | -4,017 | -1,638 | 8,015 | 9,546 |
| Depreciation Amortization | 8 | 5 | 2 | 296 | 273 |
| Accounts receivable | -45 | -28 | -22 | 106 | -429 |
| Accounts payable and accrued liabilities | 464 | 421 | 171 | -1,302 | -1,226 |
| Other Working Capital | 492 | 303 | -20 | -1,395 | -1,926 |
| Other Operating Activity | 3,253 | 2,081 | 841 | -11,823 | -12,420 |
| Operating Cash Flow | $-1,939 | $-1,235 | $-666 | $-6,104 | $-6,182 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -636 | -617 | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | -1 | -2 |
| Purchase Of Investment | -357 | -347 | N/A | N/A | N/A |
| Other Investing Activity | 147 | 70 | 0 | 5,278 | 5,387 |
| Investing Cash Flow | $-846 | $-894 | $N/A | $5,277 | $5,386 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 112 | 274 | 277 |
| Common Stock Repurchased | 1,429 | 943 | N/A | N/A | N/A |
| Other Financing Activity | -44 | -37 | -3 | -154 | -153 |
| Financing Cash Flow | $1,385 | $906 | $109 | $119 | $123 |
| Exchange Rate Effect | -42 | -39 | -17 | 113 | 76 |
| Beginning Cash Position | 4,176 | 4,051 | 3,717 | 4,391 | 4,467 |
| End Cash Position | 2,733 | 2,789 | 3,143 | 3,796 | 3,870 |
| Net Cash Flow | $-1,443 | $-1,262 | $-574 | $-595 | $-597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,939 | -1,235 | -666 | -6,104 | -6,182 |
| Capital Expenditure | N/A | N/A | N/A | -1 | -2 |
| Free Cash Flow | -1,939 | -1,235 | -666 | -6,105 | -6,183 |